Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Johnson

Showing results (271-280 of 1,026) with videos related to

Pageof 103
Sort By:
American Heart Journal|March 1, 2006
Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular functionNicole M Isbel, Brian Haluska, David W Johnson, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Fibrogenic stresses activate different mitogen-activated protein kinase pathways in renal epithelial, endothelial or fibroblast cell populationsBetty K Pat, Leila Cuttle, Dianne Watters, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 9, 2014
Prevention of peritoneal dialysis-related infectionsDenise J Campbell, David W Johnson, David W Mudge, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 29, 2016
Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot StudyRong Xu, Zhikai Yang, Zhen Qu, et al.
Nature Reviews. Nephrology|July 31, 2024
Drug repurposing for glomerular diseases: an underutilized resourceMonica Suet Ying Ng, Gursimran Kaur, Ross S Francis, et al.
The Cochrane Database of Systematic Reviews|February 18, 2011
Nebulized epinephrine for croup in childrenCandice Bjornson, Kelly F Russell, Ben Vandermeer, et al.
Therapeutic Drug Monitoring|July 17, 2004
Severe toxicity associated with a markedly elevated mycophenolic acid free fraction in a renal transplant recipientDavid W Mudge, Bronwyn A Atcheson, Paul J Taylor, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 23, 2013
Macrostructuring of emulsion-templated porous polymers by 3D laser patterningDavid W Johnson, Colin Sherborne, Matthew P Didsbury, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|April 15, 2017
Association Between Peritoneal Glucose Exposure and Peritonitis in Peritoneal Dialysis Patients: The balANZ TrialMelissa Nataatmadja, Yeoungjee Cho, Elaine M Pascoe, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2007
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysisKathryn J Wiggins, Stephen P McDonald, Fiona G Brown, et al.
Pageof 103

Showing results (271-280 of 1,026) with videos related to

Sort By:
Pageof 103
American Heart Journal|March 1, 2006
Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular functionNicole M Isbel, Brian Haluska, David W Johnson, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Fibrogenic stresses activate different mitogen-activated protein kinase pathways in renal epithelial, endothelial or fibroblast cell populationsBetty K Pat, Leila Cuttle, Dianne Watters, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 9, 2014
Prevention of peritoneal dialysis-related infectionsDenise J Campbell, David W Johnson, David W Mudge, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 29, 2016
Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot StudyRong Xu, Zhikai Yang, Zhen Qu, et al.
Nature Reviews. Nephrology|July 31, 2024
Drug repurposing for glomerular diseases: an underutilized resourceMonica Suet Ying Ng, Gursimran Kaur, Ross S Francis, et al.
The Cochrane Database of Systematic Reviews|February 18, 2011
Nebulized epinephrine for croup in childrenCandice Bjornson, Kelly F Russell, Ben Vandermeer, et al.
Therapeutic Drug Monitoring|July 17, 2004
Severe toxicity associated with a markedly elevated mycophenolic acid free fraction in a renal transplant recipientDavid W Mudge, Bronwyn A Atcheson, Paul J Taylor, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 23, 2013
Macrostructuring of emulsion-templated porous polymers by 3D laser patterningDavid W Johnson, Colin Sherborne, Matthew P Didsbury, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|April 15, 2017
Association Between Peritoneal Glucose Exposure and Peritonitis in Peritoneal Dialysis Patients: The balANZ TrialMelissa Nataatmadja, Yeoungjee Cho, Elaine M Pascoe, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2007
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysisKathryn J Wiggins, Stephen P McDonald, Fiona G Brown, et al.
Pageof 103